Efficacy and Safety of BIIB111 for the Treatment of Choroideremia
NCT03496012
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
169
Enrollment
INDUSTRY
Sponsor class
Conditions
Choroideremia
Interventions
GENETIC:
BIIB111
Sponsor
Biogen